BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2014 8:41:00 PM | Browse: 855 | Download: 653
Publication Name World Journal of Gastroenterology
Manuscript ID 3981
Country Romania
Received
2013-06-05 18:50
Peer-Review Started
2013-06-05 22:26
To Make the First Decision
2013-07-19 08:49
Return for Revision
2013-07-22 17:50
Revised
2013-08-08 16:40
Second Decision
2013-09-16 17:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-09-17 06:13
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-10-29 18:40
Publish the Manuscript Online
2013-11-18 10:59
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication
Manuscript Source Invited Manuscript
All Author List Anca Trifan, Irina Girleanu, Camelia Cojocariu, Catalin Sfarti, Ana Maria Singeap, Carmen Dorobat, Lucia Grigore and Carol Stanciu
Funding Agency and Grant Number
Corresponding Author Carol Stanciu, MD, PhD, FRCP, Institute of Gastroenterology and Hepatology, "St. Spiridon" Emergency Hospital, Independentei 1, 700111 Iasi, Romania. carolstanciu@yahoo.com
Key Words Helicobacter pylori eradication; Triple therapy; Clostridium difficile; Pseudomembranous colitis; Vancomycin
Core Tip Herein are described the cases of two elderly women who developed pseudomembranous colitis after one-week triple therapy consisting of pantoprazole (20 mg bid), clarithromycin (500 mg bid), and amoxicillin (1 g bid) to eradicate Helicobacter pylori (H. pylori) infection. After a 10-d treatment with oral vancomycin (125 mg every 6 h) both patients had complete resolution of symptoms and negative stool test for Clostridium difficile toxins. Clinicians should have a high index of suspicion of pseudomembranous colitis as a rare, but severe complication of H. pylori therapy.
Publish Date 2013-11-18 10:59
Citation Trifan A, Girleanu I, Cojocariu C, Sfarti C, Singeap AM, Dorobat C, Grigore L, Stanciu C. Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication. World J Gastroenterol 2013; 19(42): 7476-7479
URL http://www.wjgnet.com/1007-9327/full/v19/i42/7476.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i42.7476
Full Article (PDF) WJG-19-7476.pdf
Manuscript File 3981-Review.docx
Answering Reviewers 3981-Answering reviewers.pdf
Copyright License Agreement 3981-Copyright assignment.docx
Peer-review Report 3981-Peer reviewer(s).pdf
Scientific Editor Work List 3981-Scientific editor work list.doc